18F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
18F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility
Authors
Keywords
Low-grade glioma, <sup>18</sup>F-Fluorocholine PET, Advanced magnetic resonance imaging, <sup>201</sup>Tl-SPECT
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 42, Issue 6, Pages 886-895
Publisher
Springer Nature
Online
2015-02-12
DOI
10.1007/s00259-015-2997-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Focal Changes in Diffusivity on Apparent Diffusion Coefficient MR Imaging and Amino Acid Uptake on PET Do Not Colocalize in Nonenhancing Low-Grade Gliomas
- (2014) V. Rahm et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of 18F-FET PET and Perfusion-Weighted MR Imaging: A PET/MR Imaging Hybrid Study in Patients with Brain Tumors
- (2014) C. P. Filss et al. JOURNAL OF NUCLEAR MEDICINE
- Metabolic Mapping of Gliomas Using Hybrid MR-PET Imaging
- (2013) Sotirios Bisdas et al. INVESTIGATIVE RADIOLOGY
- Cerebral radiation necrosis: A review of the pathobiology, diagnosis and management considerations
- (2013) Gazanfar Rahmathulla et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET as a Diagnostic Tool for Detection of Malignant Progression in Patients with Low-Grade Glioma
- (2013) N. Galldiks et al. JOURNAL OF NUCLEAR MEDICINE
- Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head
- (2012) Koen Mertens et al. CLINICAL NUCLEAR MEDICINE
- Impact of 3,4-Dihydroxy-6-18F-Fluoro-L-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
- (2012) F. Walter et al. JOURNAL OF NUCLEAR MEDICINE
- Is there still a role for SPECT–CT in oncology in the PET–CT era?
- (2012) Rodney J. Hicks et al. Nature Reviews Clinical Oncology
- The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine
- (2012) Koen Mertens et al. NUCLEAR MEDICINE COMMUNICATIONS
- MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice
- (2011) M. Essig et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- F-18 Choline PET Does Not Detect Increased Metabolism in F-18 Fluoroethyltyrosine-Negative Low-Grade Gliomas
- (2011) Ulrich Roelcke et al. CLINICAL NUCLEAR MEDICINE
- Treatment Monitoring in Gliomas
- (2011) Jonathan Vöglein et al. INVESTIGATIVE RADIOLOGY
- Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
- (2011) MJ van den Bent et al. LANCET ONCOLOGY
- Neuroimagen de los tumores cerebrales
- (2011) J. Arbizu et al. Revista Espanola de Medicina Nuclear
- Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors—Early experience
- (2010) Winnie Wing-Chuen Lam et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
- (2010) Frederic G Dhermain et al. LANCET NEUROLOGY
- Thallium-201 SPECT in Brain Gliomas
- (2009) Simeon J. Ortega-Lozano et al. CLINICAL NUCLEAR MEDICINE
- Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence
- (2008) Manuel Gómez-Río et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now